Physical radiotherapy treatment planning based on functional PET/CT data.
暂无分享,去创建一个
[1] D. Olsen,et al. Radiotherapy adapted to spatial and temporal variability in tumor hypoxia. , 2007, International journal of radiation oncology, biology, physics.
[2] Bernhard Sattler,et al. PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] W. Oyen,et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[4] Barbara Vanderstraeten,et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.
[5] H. Zaidi,et al. Molecular PET/CT imaging-guided radiation therapy treatment planning. , 2009, Academic radiology.
[6] Aswin L Hoffmann,et al. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer? , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Xavier Geets,et al. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] Joe Y. Chang,et al. GTV spatial conformity between different delineation methods by 18FDG PET/CT and pathology in esophageal cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] S Mutic,et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. , 2001, International journal of radiation oncology, biology, physics.
[10] I. Buvat,et al. Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.
[11] Daniela Thorwarth,et al. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia , 2005, Physics in medicine and biology.
[12] M. Schwaiger,et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.
[13] H. Thierens,et al. Implementation of biologically conformal radiation therapy (BCRT) in an algorithmic segmentation-based inverse planning approach , 2006, Physics in medicine and biology.
[14] M Alber,et al. On biologically conformal boost dose optimization. , 2003, Physics in medicine and biology.
[15] Sadek Nehmeh,et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.
[16] Gig Mageras,et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.
[17] Daniela Thorwarth,et al. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations. , 2007, International journal of radiation oncology, biology, physics.
[18] Søren M Bentzen,et al. Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.
[19] M. Eble,et al. Dose-escalation using intensity-modulated radiotherapy for prostate cancer--evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] Josien P. W. Pluim,et al. Image registration , 2003, IEEE Transactions on Medical Imaging.
[21] H. Thierens,et al. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] Ellen Yorke,et al. 18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy* , 2009, Journal of Nuclear Medicine.
[23] Ursula Nestle,et al. Biological imaging in radiation therapy: role of positron emission tomography , 2009, Physics in medicine and biology.
[24] Anne Bol,et al. The limitation of PET imaging for biological adaptive-IMRT assessed in animal models. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] P. Grigsby,et al. Prospective clinical trial of positron emission tomography/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes. , 2008, International journal of radiation oncology, biology, physics.
[26] Jens Overgaard,et al. Resolution in PET hypoxia imaging: Voxel size matters , 2008, Acta oncologica.
[27] Matthias Reimold,et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] Wolfgang Enghardt,et al. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning? , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[29] Johannes A Langendijk,et al. Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] David L. Schwartz,et al. Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer , 2006, Clinical Cancer Research.
[31] Daniela Thorwarth,et al. Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[32] Robert Jeraj,et al. On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function , 2009, Physics in medicine and biology.
[33] W. Oyen,et al. 18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors , 2010, Journal of Nuclear Medicine.
[34] Barbara Vanderstraeten,et al. Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo, convolution/superposition, and pencil beam computations. , 2006, Medical physics.
[35] Lester J. Peters,et al. Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[36] R. Haubner. PET radiopharmaceuticals in radiation treatment planning - synthesis and biological characteristics. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[37] C C Ling,et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.
[38] Ping Xia,et al. Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT? , 2009, International Journal of Radiation Oncology, Biology, Physics.
[39] Ludy Lutgens,et al. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. , 2005, International journal of radiation oncology, biology, physics.
[40] W. Oyen,et al. 18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients , 2007, Journal of Nuclear Medicine.
[41] John L. Humm,et al. Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging , 2008, Physics in medicine and biology.
[42] Richard A Popple,et al. Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. , 2002, International journal of radiation oncology, biology, physics.
[43] Sadek Nehmeh,et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. , 2008, International journal of radiation oncology, biology, physics.
[44] P. Lambin,et al. Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[45] P. Keall. 4-dimensional computed tomography imaging and treatment planning. , 2004, Seminars in radiation oncology.
[46] Robert Jeraj,et al. Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. , 2008, Physics in medicine and biology.
[47] Daniela Thorwarth,et al. Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.
[48] Mark Muzi,et al. [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure. , 2006, International journal of radiation oncology, biology, physics.
[49] Tomio Inoue,et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[50] Andrea Schaefer,et al. A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[51] Olivier Barret,et al. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[52] X Allen Li,et al. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. , 2006, International journal of radiation oncology, biology, physics.
[53] K Schnabel,et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. , 1999, International journal of radiation oncology, biology, physics.
[54] J. Mountz,et al. Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation , 2009, Nuclear medicine communications.
[55] L. Bogner,et al. A Biologically Adapted Dose-Escalation Approach, Demonstrated for 18F-FET-PET in Brain Tumors , 2008, Strahlentherapie und Onkologie.
[56] Sigrid Stroobants,et al. Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI , 2009, Journal of Nuclear Medicine.
[57] Xavier Geets,et al. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[58] P. Lambin,et al. Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[59] Andrew J Reader,et al. The promise of new PET image reconstruction. , 2008, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[60] Dag Rune Olsen,et al. Strategies for biologic image-guided dose escalation: a review. , 2009, International journal of radiation oncology, biology, physics.
[61] H. Minn,et al. Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[62] Habib Zaidi,et al. 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[63] M. Kessler,et al. Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[64] O. Hoekstra,et al. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[65] J. Lee,et al. Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[66] D. Mankoff,et al. Hypoxia imaging-directed radiation treatment planning , 2006, European Journal of Nuclear Medicine and Molecular Imaging.